Gebhardt S, Röttgers H, Bäcker A, Schu U, Krieg J-C
Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.
J Clin Pharm Ther. 2008 Oct;33(5):575-7. doi: 10.1111/j.1365-2710.2008.00952.x.
We report on a 57-year-old woman, diagnosed with Parkinson's disease, whose panic disorder showed marked improvement after introduction of bupropion, a norepinephrine-dopamine reuptake inhibitor. Additionally a comorbid major depression disappeared under this treatment. Bupropion may be useful for the treatment of patients with both panic disorder and Parkinson's disease.
我们报告了一名57岁被诊断为帕金森病的女性患者，其惊恐障碍在使用去甲肾上腺素-多巴胺再摄取抑制剂安非他酮后有显著改善。此外，一种共病的重度抑郁症在这种治疗下也消失了。安非他酮可能对治疗同时患有惊恐障碍和帕金森病的患者有用。
